In contrast, in prostate adenocarcinoma tissues, UCP2 expression is reduced (Figure 3C), while several MAM-stabilizing proteins, including AKAP1, RICTOR, GPR75, and PEMT1, were found to be upregulated (Figure 3D). The gene discussed is UCP2; the disease is prostate adenocarcinoma.